Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Comment by hydrabioon Sep 07, 2017 11:57am
103 Views
Post# 26666707

RE:RE:RE:I'm Mark Kunzli, Director of Pharmacy Solutions at VANC

RE:RE:RE:I'm Mark Kunzli, Director of Pharmacy Solutions at VANC
Thanks. However, you said you were here with the company and what the company is doing. Your replies here hide behind "I wasn't here when that happened" so that doesn't really help. However, you could comment on the corporate account strategy, pricing strategy, What your PA allowances plan is, what the contingency plan for Pan-Canadian further price decreases, what the plan is for replenishment of expired stock in the supply chain, what the pipeline looks like for more generic contracts (since you don't have a pipeline for manufacturing) Why is the presence in Ontario lacking for Vanc at all levels? Whats the plan to increase Marketshare in Ontario for generics? and how?
Bullboard Posts